Advertisement

Topics

How ElevateBio plans to create portfolio of cell, gene therapy newcos with $150M MPM, F2-led round

12:30 EDT 13 May 2019 | BioCentury

Led by Alexion, bluebird veterans, ElevateBio launches to build internal manufacturing capabilities and spin out cell and gene therapy companies.

Original Article: How ElevateBio plans to create portfolio of cell, gene therapy newcos with $150M MPM, F2-led round

NEXT ARTICLE

More From BioPortfolio on "How ElevateBio plans to create portfolio of cell, gene therapy newcos with $150M MPM, F2-led round"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...